Notice

Life Sciences Innovative Manufacturing Fund (LSIMF): ExpressionPhase of2 Interest(closed to applications)

The~~This~~ Life~~fund~~ Sciencesis Innovativeto Manufacturing~~support~~ Fund supports businesses investing in life sciences manufacturing projects in the UK.

From:: Department for Science, Innovation and Technology and Office for Life Sciences
Published: 2 March 2022
Last updated: 3126 October~~February~~ 2024 — See all updates

Documents

Life Sciences Innovative Manufacturing FundFund: (LSIMF):scheme applicationguidance guide(updated 2 May 2023)

HTML~~PDF~~, ~~324~~ KB, 13 ~~pages~~

Grant offer letter: draft template

~~PDF~~, ~~320~~ KB, 15 ~~pages~~

~~This~~ ~~file~~ ~~may~~ ~~not~~ be ~~suitable~~ ~~for~~ ~~users~~ of ~~assistive~~ ~~technology.~~

~~Request~~ an ~~accessible~~ ~~format.~~

If ~~you~~ ~~use~~ ~~assistive~~ ~~technology~~ ~~(such~~ as a ~~screen~~ ~~reader)~~ ~~and~~ ~~need~~ a ~~version~~ of ~~this~~ ~~document~~ in a ~~more~~ ~~accessible~~ ~~format,~~ ~~please~~ ~~email~~ ~~alt.formats@dsit.gov.uk~~. ~~Please~~ ~~tell~~ us ~~what~~ ~~format~~ ~~you~~ ~~need.~~ It ~~will~~ ~~help~~ us if ~~you~~ ~~say~~ ~~what~~ ~~assistive~~ ~~technology~~ ~~you~~ ~~use.~~

Life Sciences Innovative Manufacturing FundFund: (LSIMF): privacy notice

HTML

Details

31~~The~~ October~~Life~~ 2024:~~Sciences~~ update~~Innovative~~ ~~Manufacturing~~ ~~Fund~~ (~~LSIMF~~) ~~Phase~~ 2 is ~~now~~ ~~closed~~ to ~~new~~ ~~applications.~~

Background and objectives of the programme

The Life Sciences Innovative Manufacturing Fund (LSIMF) is open~~part~~ of ~~the~~ ~~Global~~ ~~Britain~~ ~~Investment~~ ~~Fund~~ and will accept~~provide~~ Expression~~£60~~ ~~million~~ in ~~capital~~ ~~grants~~ ~~for~~ ~~investment~~ in ~~the~~ ~~manufacture~~ ~~of:~~

~~human~~ ~~medicines~~ ~~(drug~~ ~~substance~~ ~~and~~ ~~drug~~ ~~product)~~

~~medical~~ ~~diagnostics~~

~~MedTech~~ ~~products~~

We ~~have~~ ~~already~~ ~~announced~~ ~~the~~ ~~first~~ ~~tranche~~ of Interests~~companies~~ (EOIto be ~~supported~~ by ~~LSIMF~~) on~~and~~ a~~are~~ rolling~~now~~ basis.~~re-opening~~ ~~the~~ ~~fund~~ ~~with~~ ~~the~~ ~~remaining~~ ~~budget~~ of ~~£7.6~~ ~~million.~~

Specific themes

TheWe government’s~~particularly~~ plan~~welcome~~ for~~applications~~ Life~~from~~ Sciences~~companies~~ –~~with~~ ‘A~~manufacturing~~ Prescription~~investments~~ for~~that~~ Growth’~~demonstrate~~ committed~~the~~ up~~adoption~~ toof £520~~innovative~~ million~~process~~ ~~technologies,~~ for life~~example:~~

~~flexible~~ sciences~~manufacturing enabling~~ manufacturing,~~rapid~~ to~~product~~ help~~switching~~

~~continuous~~ deliver~~manufacturing~~

~~technologies~~ ~~that~~ ~~will minimise~~ ~~impact~~ of ~~the~~ ~~product~~ or ~~the~~ ~~manufacturing~~ ~~process~~ on the government’s~~environment~~

~~digital~~ missions~~twins,~~ to~~which~~ kickstart~~harness~~ economic~~the~~ growth~~power~~ of ~~data~~ ~~analytics~~ and build~~modelling~~ anto NHS~~optimise~~ fit~~manufacturing~~ for~~processes~~

~~This~~ ~~list~~ is ~~not~~ ~~exhaustive.~~

Fund objectives

We ~~will~~ ~~prioritise~~ ~~applicants~~ ~~based~~ on ~~their~~ ~~alignment~~ to the future.~~fund’s~~ ~~objectives:~~

The1. ~~Creating~~ LSIMF~~economic~~ ~~opportunity~~ ~~through~~ ~~investments~~ ~~that~~ will be~~provide~~ UK~~high-wage,~~ and~~high-skilled~~ sector~~jobs.~~

2. ~~Deploying~~ wide~~cutting-edge~~ ~~innovations~~ ~~(at~~ ~~both~~ ~~pilot~~ and will~~commercial~~ provide~~scale)~~ capital~~which~~ grants~~can~~ forbe investments~~embedded~~ in ~~either~~ the manufacture~~product~~ of:~~itself~~ or ~~the~~ ~~manufacturing~~ ~~process.~~

Human
3. ~~Increasing~~ medicines~~health~~ (this~~resilience~~, includes~~either~~ both~~through~~ the~~increased~~ manufacture~~domestic~~ of~~capacity~~ activeor pharmaceuticalby ingredients~~providing~~ (API)~~flexible~~ /~~capabilities~~ drug~~that~~ substance~~can~~ andbe finished~~re-deployed~~ productin /~~some~~ drug~~way~~ product).

Medicalin diagnosticsa –~~future~~ for~~health~~ both~~emergency.~~

4. ~~Minimising~~ disease~~impact~~ identificationon and~~the~~ monitoring.

MedTech~~environment~~, products~~which~~ –~~might~~ all~~include~~ types~~reduction~~ ofin medical~~input~~ devices~~resources~~ relatedor ~~using~~ ~~alternative~~ ~~input~~ ~~materials~~ to human~~become~~ health.

This~~more~~ guidance~~sustainable~~ includesor information~~support~~ about~~the~~ ~~government’s~~ ~~net~~ ~~zero~~ ~~target.~~

Contact

~~Contact~~ ~~the~~ LSIMF and~~support~~ ~~team~~ if ~~you~~ ~~have~~ ~~any~~ ~~queries~~ ~~about~~ the application~~fund:~~ process.~~LSIMF@officeforlifesciences.gov.uk~~.

Published 2 March 2022
Last updated 3126 October~~February~~ 2024 + show all updates

31 October 2024
The Life Sciences Innovative Manufacturing Fund (LSIMF) is open and will accept Expression of Interests (EOI) on a rolling basis.

26 February 2024
Life Sciences Innovative Manufacturing Fund (LSIMF): Phase 2 closed to applications.
2 May 2023
Phase 2 open to Expressions of Interest.
23 June 2022
Phase 1 is now closed to Expressions of Interest.
3 May 2022
Submit expressions of interest for Phase 1, Wave 3 by 31 May 2022, 12 noon.
7 April 2022
Wave 2 expressions of interest date added.
7 April 2022
Date for submitting expressions of interest to the LSIMF Phase 1 Wave 1 changed to Friday 29 April at 12 noon.
2 March 2022
First published.